Oura seeks $2.2B IPO while partnering with Dexcom and Resmed
1 report, 1 independent
Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Oura announced partnerships with Dexcom and Resmed to integrate health features into their respective products. The company also disclosed a plan to seek up to $2.2 billion in an initial public offering, estimating shares will be valued between $40 and $44 each.
From yahoo.com
Why it matters
The partnerships allow Oura to expand its health feature offerings by integrating with established medical technology companies. Oura is operating in a market where the distinction between wellness features and regulated medical devices is a key challenge, particularly regarding FDA oversight.
From yahoo.com
Who's involved
- OuraWearables firm seeking IPO and integrating health features
- DexcomCompany developing continuous glucose monitoring systems, partnering with Oura
- ResmedManufacturer of respiratory condition products, partnering with Oura
- Goldman SachsLead underwriter for Oura's Initial Public Offering
- RobinhoodUnderwriter for Oura's upcoming Initial Public Offering